Sort
15,842 grants matching “pancreatic cancer”
Studies of Human T Regulatory Cells
$970,827Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
High Cell Density Bioartificial Pancreas Enabled by Implantable Oxygen Generator
$969,848Linda A Tempelman · Giner, Inc. · R44 · FY2016 · DK
Biological Functions of Chromosomal Proteins
$969,817Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Thoracic and Gastrointestinal Malignancies Branch Clinical Core
$968,567Raffit Hassan · Division Of Basic Sciences - Nci · ZID · FY2025 · CA
Robust Predictor of Colon Cancer Risk
$968,518Harry Ostrer · Morgan And Mendel Genomics, Inc. · R42 · FY2022 · CA
Evolution of Primary and Resistant Solid Tumors
$968,176Ronald Anthony Depinho · Dana-Farber Cancer Inst · U01 · FY2008 · CA
Novel approaches to improve prediction of cancer-associated thrombosis
$967,487Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · U01 · FY2021 · HL
Clinical Validation Center for Early Detection of Pancreatic Cancer
$965,837Anirban Maitra · University Of Tx Md Anderson Can Ctr · U01 · FY2024 · CA
Identifying Metabolic Dependencies of Pancreatic Cancers
$964,796Alec Kimmelman · New York University School Of Medicine · R35 · FY2024 · CA
Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity
$964,277Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2024 · CA
Molecular, Cellular, and Tissue Characterization Unit
$964,136William E Gillanders · Washington University · U2C · FY2019 · CA
In vivo gene detection for cancer analysis
$964,018Gang Bao · Vivonetics, Inc. · R42 · FY2006 · CA
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
$963,693William C Hahn · Dana-Farber Cancer Inst · U01 · FY2022 · CA
Pancreatic Ductal Adenocarcinoma Targeted Ultrasound Contrast Agent Development
$963,578Evan Charles Unger · Nuvox Pharma, Llc · R44 · FY2018 · CA
Cellular In vivo Imaging
$963,353Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
$963,150William C Hahn · Dana-Farber Cancer Inst · U01 · FY2021 · CA
Development of a protein drug for pancreatic cancer treatment
$962,484Zhi-Ren Liu · Proda Biotech, Llc · U44 · FY2022 · CA
Molecular Imaging and Theranostics of Cancer
$962,425Zaver M Bhujwalla · Johns Hopkins University · R35 · FY2022 · CA
Molecular Imaging and Theranostics of Cancer
$962,412Zaver M Bhujwalla · Johns Hopkins University · R35 · FY2023 · CA
Predicting pancreatic cancer responses for a Parp inhibitor-based clinical trial
$962,168Michael G. Goggins · Johns Hopkins University · RC2 · FY2010 · CA
Novel approaches to improve prediction of cancer-associated thrombosis
$960,071Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · U01 · FY2020 · HL
United for Health Equity - Living PDX Program (U4HELPP)
$960,065Jose G. Trevino · Virginia Commonwealth University · U54 · FY2024 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2018 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2020 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2017 · CA